MedTrace Logo

Effects of PRK 124 Lotion in Acne Rosacea

NCT00580723 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2014-01-17

Study results available
· View outcomes & findings →

Summary

The purpose of this open-label study is to determine the tolerance and efficacy of twice-daily application of PRK 124 (Pyratine-6)(0.125%) moisturizing lotion for improving the signs and symptoms of mild to moderate facial rosacea.

Conditions

  • Acne Rosacea

Interventions

OTHER

PRK 124

Topical PRK 124 (0.125%) moisturizing lotion applied twice daily to the face for 48 weeks

Sponsors & Collaborators

  • SenetekPLC

    collaborator UNKNOWN

  • University of California, Irvine

    lead OTHER

Principal Investigators

  • Gerald D Weinstein, MD · University of California, Irvine

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-04-30
Primary Completion
2009-02-28
Completion
2009-02-28

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00580723 on ClinicalTrials.gov